Quarterly report [Sections 13 or 15(d)]

Other Income / (Expense)

v3.25.4
Other Income / (Expense)
6 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Other Income / (Expense)

Note 10. Other Income / (Expense):

The components of Other income (expense) in the accompanying Condensed Consolidated Statement of Earnings and Comprehensive Income are as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Quarter Ended

​

​

Six Months Ended

​

​

December 31, 

​

​

December 31, 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

2025

  ​ ​ ​

2024

Interest expense

​

$

(2,171)

​

$

(2,148)

​

$

(5,105)

​

$

(4,324)

Interest income

​

​

897

​

​

1,348

​

​

1,868

​

​

2,274

Gain (loss) on equity method investment

​

​

110

​

​

46

​

​

404

​

​

420

Other non-operating income (expense), net(1)

​

 

(2,513)

​

 

(3,789)

​

​

(511)

​

 

(2,729)

Total other income (expense)

​

$

(3,677)

​

$

(4,543)

​

$

(3,344)

​

$

(4,359)

(1) Fiscal 2026 primarily relates to the change in stock valuation for MDxHealth.